Does REPAGLINIDE Cause Interstitial lung disease? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Interstitial lung disease have been filed in association with REPAGLINIDE (Repaglinide). This represents 1.0% of all adverse event reports for REPAGLINIDE.
26
Reports of Interstitial lung disease with REPAGLINIDE
1.0%
of all REPAGLINIDE reports
0
Deaths
23
Hospitalizations
How Dangerous Is Interstitial lung disease From REPAGLINIDE?
Of the 26 reports, 23 (88.5%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REPAGLINIDE. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does REPAGLINIDE Cause?
Hypoglycaemia (665)
Acute kidney injury (281)
Lactic acidosis (163)
Hypoglycaemic coma (125)
Sopor (91)
Confusional state (89)
Drug interaction (89)
Blood glucose increased (88)
Diarrhoea (87)
Dyspnoea (87)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which REPAGLINIDE Alternatives Have Lower Interstitial lung disease Risk?
REPAGLINIDE vs REPOTRECTINIB
REPAGLINIDE vs REQUIP
REPAGLINIDE vs RESLIZUMAB
REPAGLINIDE vs RESMETIROM
REPAGLINIDE vs RESTASIS